Glucopento decoction, a traditional Vietnamese medicine (VTM) formula, is composed of Gymnema sylvestre, Scrophularia nodosa, Physalis angulata, Gymnanthemum amygdalinum, and Oroxylum indicum, and has long been used as supportive therapy for type 2 diabetes mellitus (T2DM), though its active constituents have remain unclear. This study performs, an ultra-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry (UPLC–QTOF-MS/MS) method for both positive and negative ion modes was established to investigate the major constituents in Glucopento decoction. Purospher® STAR RP-18 (150 mm x 4,6 mm, 3 µm) column was employed for chromatographic separation, with acetonitrile and 0.1% aqueous formic acid (v/v) as the mobile phase. A total of twenty-seven compounds, including flavonoids and their glycosides, coumarins, triterpenoid saponins, iridoid and phenylethanoid glycosides, withanolides/physalins, terpenoids, and alkaloids, were tentatively characterized based on accurate mass measurement and MS/MS fragmentation behavior. Furthermore literature mining further indicated that more than half of these constituents possess documented antidiabetic or hypoglycemic activities in vitro and in vivo. These results provide a comprehensive phytochemical profile of Glucopento decoction, offering a basis for elucidating its pharmacological mechanisms and supporting its further development as a safe adjunct therapy against type 2 diabetes.